RecruitingReducing Pain With Nexplanon Implant Insertion
Vapocoolant Spray to Reduce Pain With Nexplanon Insertion
Eligible age
14+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.
Sponsor: Queen's Medical Center
You may qualify if…
- ✓ At least 14 years or older
- ✓ Undergoing an etonogestrel implant insertion in the arm in POB1 Suite 1004 or POB2 Suite 402
- ✓ English speaking
- ✓ Able and willing to sign the informed consent form and agree to terms of the study
You may not qualify if…
- ✕ Required or requested narcotics, anxiolytics, IV sedation, or general anesthesia for the procedure
- ✕ Known previous exposure to vapocoolant spray
- ✕ Nexplanon removal and reinsertion same day during visit in the same arm
- ✕ Contraindications to vapocoolant spray components (ethyl chloride and 1,1,1,3,3-pentafluoropropane/1,1,1,2-tetrafluroethane)
- ✕ Unable to provide written, informed consent in English
Where it's recruiting
Hawaii
Honolulu · Waimea
Source: ClinicalTrials.gov · NCT06933381 · last updated 2026-01-09